The largest database of trusted experimental protocols

Amoxycillin clavulanic acid

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom

Amoxycillin-clavulanic acid is a combination antibiotic medication used to treat a variety of bacterial infections. It consists of the antibiotic amoxicillin and the beta-lactamase inhibitor clavulanic acid. The core function of this product is to provide broad-spectrum antimicrobial activity against a wide range of gram-positive and gram-negative bacteria.

Automatically generated - may contain errors

7 protocols using amoxycillin clavulanic acid

1

Antibacterial Activity of Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibacterial activity of each EO and mixture was tested by Kirby-Bauer agar disc diffusion method following the procedures previously described [12 (link)]. A 1:10 dilution in dimethyl sulfoxide (DMSO, Oxoid Ltd., Basingstoke, Hampshire, UK) of each EO and mixture was assayed. All tests were performed in triplicate.
The in vitro sensitivity of E. coli strain to amoxycillin-clavulanic acid (30 μg) (Oxoid) was evaluated by Kirby-Bauer method and the results were interpreted as indicated by Clinical and Laboratory Standards Institute [13 ].
+ Open protocol
+ Expand
2

Antibacterial Activity of Thymoquinone (TQ)

Check if the same lab product or an alternative is used in the 5 most similar protocols
TQ was procured from Sigma-Aldrich (Milwaukee, Wis., USA) and had a purity of 99.0%. FT-IR was performed to validate the identity and purity of TQ [1 (link)]. The penicillin (2 µg), erythromycin (10 µg), ampicillin (30 µg), amoxicillin (25 µg), amoxycillin/clavulanic acid (30 µg), cefotaxime (30 µg), gentamycin (10 µg), chloramphenicol (30 µg), tetracycline (30 µg), and imipenem (10 µg) antibiotic discs were procured from Oxoid Limited, United Kingdom.
+ Open protocol
+ Expand
3

Phenotypic Confirmation of ESBL Producers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic confirmation of ESBL producers was carried out using the double disc method using cefotaxime (30 µg), ceftazidime (30 µg), and amoxycillin/clavulanic acid (20 + 10 µg) (Oxoid, Basingstoke, Hampshire, UK)) [28 (link)]. This test was also applied to all the E. coli isolates.
+ Open protocol
+ Expand
4

Antibacterial Activity of Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial activity of both EOs was determined with the Agar disk diffusion method following the procedures described by Clinical and Laboratory Standards Institute (CLSI) [27 ] and with some modifications as previously described [28 (link)]. Each EO was tested at a 1:10 dilution in dimethyl sulfoxide (DMSO, Oxoid Ltd.). An absorbent paper disc impregnated with 10 µL of DMSO was used as negative control. Paper discs impregnated with amikacin (30 µg), amoxycillin-clavulanic acid (30 μg), cefotaxime (30 µg), tetracycline (30 µg) (Oxoid Ltd.), respectively, were used as positive controls. The results of the bacterial in vitro sensitivity to antibiotics were interpreted as indicated by the CLSI [29 ]. All tests were performed in triplicate.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility of E. coli and Enterococcus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro sensitivity of each E. coli and Enterococcus spp. strain to the following antibiotics (Oxoid Ltd. Basingstoke, Hampshire, UK) was tested: aztreonam (30 µg), amikacin (30 µg), amoxycillin-clavulanic acid (30 μg), ampicillin (10 µg), cephalothin (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), cephalexin (30 µg), ciprofloxacin (5 µg), colistin sulfate (10 µg), doxycycline (30 µg), erythromycin (10 µg), enrofloxacin (5 µg), gentamicin (10 µg), neomycin (30 µg), piperacillin (100 µg), rifampicin (30 µg), streptomycin (10 µg), sulphametoxazole-trimethoprim (25 µg), tetracycline (30 µg), tobramycin (10 µg). The in vitro sensitivity to the antibiotics was evaluated by Kirby-Bauer agar disk diffusion method and the results were interpreted as indicated by the National Committee for Clinical Laboratory Standards (NCCLS) [45 ].
Antibacterial activity of each EO was tested by Kirby-Bauer agar disk diffusion method following the procedures reported by Clinical and Laboratory Standards Institute (CLSI) [46 ] with some modifications. In details, each EO and mixture was diluted 1:10 in dimethyl sulfoxide (DMSO, Oxoid Ltd.) and one absorbent paper disk was impregnated with 10 µL of each dilution, respectively. A paper disk impregnated with 10 µL of DMSO was included as negative control. All tests were performed in triplicate.
+ Open protocol
+ Expand
6

Synthesis of Curcumin-Silver Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zinc acetate dihydrate LR (Zn(CH3COO)2·2H2O, 98.5%) is purchased from SD-Fine Chem Limited. Silver nitrate (AgNO3) was purchased from Techno Pharm-Chem 99%. Ethanol absolute (C2H5OH, EtOH Central Drug House (P) LTD. 95%), polyvinylpyrrolidone (PVP 40K, Alpha Chemika 99%), Curcuma longa powder obtained from the local market. Pure curcumin purchased from Herbal house centres, Egypt – Lot No. HHC092021). Mueller-Hinton Agar (Oxoid Limited, Cat. No. CM0337), antibiotics including amikacin, amoxycillin/clavulanic acid, tigecycline, cefepime, cefotaxime, ceftazidime, cefaclor, ciprofloxacin, gentamicin, imipenem, meropenem, levofloxacin, tetracycline, tobramycin, cefazolin, cefoxitin are purchases from Oxoid Limited.
+ Open protocol
+ Expand
7

Antibiotic Susceptibility Testing of Microbes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility test by disk diffusion was performed and interpreted according to the Clinical Laboratory Standards Institute (CLSI) guidelines M100-S29with antibiotics ampicillin (10 µg), amoxycillin-clavulanic acid (20 µg/10 µg), ampicillin-sulbactam (10 µg/10 µg), cefuroxime (30 µg), ceftriaxone (30 µg), cefotaxime (30 µg), meropenem (10 µg), levo oxacin (5 µg), sulfamethoxazoletrimethoprim (1.25/23.75 µg), azithromycin (15 µg), and chloramphenicol (30 µg) (Oxoid, UK). βlactamase was measured using the ce nase disc method (BioMérieux, France). H. in uenzae strain ATCC49247 was used for quality control throughout the test. Multi-Drug Resistance (MDR) was de ned as resistant to three or more than three different types of antibiotics.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!